Authors: CARROLL TA MALTBY E ROYDS J TIMPERLEY WR JELLINEK D

Citation: Ta. Carroll et al., TELOMERASE ACTIVITY AND DICENTRIC CHROMOSOMES IN MENINGIOMAS, Journal of pathology, 182, 1997, pp. 6-6

Authors: GRIERSON AJ HODGKINS MA HANCOCK BW GOEPEL JR ROYDS J GOYNS MH

Citation: Aj. Grierson et al., INVESTIGATION OF THE RB-1 TUMOR-SUPPRESSOR GENE IN A UNITED-KINGDOM SERIES OF NON-HODGKINS-LYMPHOMAS, Leukemia & lymphoma, 23(3-4), 1996, pp. 353

Authors: FINNEGAN MCM ROYDS J GOEPEL JR LORIGAN P HANCOCK BW GOYNS MH

Citation: Mcm. Finnegan et al., MDR-1 EXPRESSION IN NON-HODGKINS-LYMPHOMAS IS UNRELATED TO TREATMENT INTENSITY OR RESPONSE TO THERAPY, Leukemia & lymphoma, 18(3-4), 1995, pp. 297

Authors: LEE KA FINNEGAN MCM SHERIDAN E HANCOCK BW GOEPEL JR ROYDS J GOYNS MH

Citation: Ka. Lee et al., ANALYSIS OF THE P53 GENE, ITS EXPRESSION AND PROTEIN STABILIZATION INNON-HODGKINS-LYMPHOMAS, Annals of oncology, 5, 1994, pp. 190000085-190000088

Authors: FINNEGAN MCM GOEPEL JR ROYDS J HANCOCK BW GOYNS MH

Citation: Mcm. Finnegan et al., ELEVATED LEVELS OF MDM-2 AND P53 EXPRESSION ARE ASSOCIATED WITH HIGH-GRADE NON-HODGKINS-LYMPHOMAS, Cancer letters, 86(2), 1994, pp. 215-221

Authors: FOX SB PERSAD RA ROYDS J KORE RN SILCOCKS PB COLLINS CC

Citation: Sb. Fox et al., P53 AND C-MYC EXPRESSION IN STAGE A1 PROSTATIC ADENOCARCINOMA - USEFUL PROGNOSTIC DETERMINANTS, The Journal of urology, 150(2), 1993, pp. 490-494